UK pharmacies braced for surge in demand as Wegovy pill now available
Pharmacies in the UK are “bracing themselves” for a surge in patients starting weight loss drugs as the…
Canada approves generic version of Wegovy for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
What to know about Medicare’s $50 GLP-1 program
NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper…
Pharmacy expert calls for hybrid digital-human models in NHS healthcare
A pharmacy academic from Kingston University has provided special expertise to the UK Parliament on two key Health…
Lost weight is less likely to return when exercise follows obesity treatment
Exercise may offer a modest but measurable defense against weight regain after dieting or bariatric surgery, but the…
Can Wegovy Pill’s Europe Push Help NVO Offset Mounting Pressures?
Last week, Novo Nordisk NVO secured a key regulatory win with the U.K. approval of the Wegovy pill…
Regulators issue warning on ads for unlicensed weight loss drugs – Chemist+Druggist
Regulators issue warning on ads for unlicensed weight loss drugs Chemist+DruggistFirst GLP-1 tablet for weight loss approved in the…
No Whey Around It: What Whey Protein Shortages Mean For Food Brands
Supply constraints are driving higher costs, reformulations, and tougher choices for food brands. getty Call it a “Whey…
Walking 6K, 12K or 18K steps a day? Fitness coach reveals how many pounds of fat you could lose
If you’re looking for a sustainable way to lose weight, the answer could be as simple as putting…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new…